Sign In

Santiago Miriuka

Co-Founder & CEO MultiplAI Health

Dr. Santiago Miriuka, MD, MSc, PhD, is a seasoned professional with over 20 years of experience in clinical cardiology, heart failure, and heart transplantation across Argentina and Canada.

He is the Co-Founder and CEO of MultiplAI Health, an innovative startup focused on revolutionizing the diagnosis of cardiovascular diseases through the development of a cutting-edge RNA liquid biopsy.

Dr. Miriuka leads one of the largest stem cell research labs in Latin America, where he explores advanced methodologies such as applied AI, RNA sequencing, and other innovative techniques to address contemporary medical challenges.

His passion for AI extends to leveraging algorithmic capabilities and data transformation strategies to combat complex diseases, showcasing his commitment to medical innovation.

Dr. Miriuka pursued his education diligently, obtaining degrees including an MD from Universidad Nacional de La Plata, a PhD from the same institution, and specialization in Cardiology from Universidad de Buenos Aires.

Furthermore, he honed his skills through Clinical and Research Fellowships in Heart Failure and Heart Transplantation at the University of Toronto, where he also completed Master of Science degrees in Cell Biology and Clinical Trials from the Institute of Medical Sciences.

Additionally, he expanded his academic horizons by achieving a Master of Science in Clinical Trials from the London School of Hygiene and Tropical Medicine, U. of London.

With a diverse background and an entrepreneurial spirit, Dr. Miriuka has held significant roles such as CEO and Former Co-Founder of MultiplAI Health, reinforcing his leadership in the healthcare innovation sector.

His previous affiliations include serving as a Clinical Investigator at CONICET and an Investigator in Cardiology at FLENI, underlining his extensive involvement in research and medical institutions.

Highlights

Sep 24 · Nature.com
Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer ... - Nature.com
Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear t
Oct 16 · SciDev.Net
AI predicts a healthier future for Latin America - SciDev.Net
Santiago Miriuka
Add to my network

Location

Buenos Aires, Buenos Aires Province, Argentina